
Noble E. Jarrell
Examiner (ID: 19030)
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1625, 1699, 1609, 1624, 1622, 1629 |
| Total Applications | 1452 |
| Issued Applications | 961 |
| Pending Applications | 170 |
| Abandoned Applications | 340 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14624505
[patent_doc_number] => 20190225620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => IMIDAZOPYRIDAZINE COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES
[patent_app_type] => utility
[patent_app_number] => 16/339744
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339744
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339744 | Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses | Oct 1, 2017 | Issued |
Array
(
[id] => 15163213
[patent_doc_number] => 10487086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Macrocycles as factor XIa inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/718431
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96214
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15718431
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/718431 | Macrocycles as factor XIa inhibitors | Sep 27, 2017 | Issued |
Array
(
[id] => 16360972
[patent_doc_number] => 20200317723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Bioconjugation of Polypeptides
[patent_app_type] => utility
[patent_app_number] => 16/650357
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650357
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650357 | Bioconjugation of polypeptides | Sep 26, 2017 | Issued |
Array
(
[id] => 12124997
[patent_doc_number] => 20180008583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/712815
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 29886
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15712815
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/712815 | METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF | Sep 21, 2017 | Abandoned |
Array
(
[id] => 15666393
[patent_doc_number] => 10597414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-OXO-2l5-[1,2]oxaphosphinane
[patent_app_type] => utility
[patent_app_number] => 16/332983
[patent_app_country] => US
[patent_app_date] => 2017-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 7297
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16332983
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/332983 | Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-OXO-2l5-[1,2]oxaphosphinane | Sep 18, 2017 | Issued |
Array
(
[id] => 12241206
[patent_doc_number] => 20180074068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'FLUORESCENT PROBES FOR DETECTING HYDROGEN POLYSULFIDES'
[patent_app_type] => utility
[patent_app_number] => 15/704101
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8727
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15704101
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/704101 | Fluorescent probes for detecting hydrogen polysulfides | Sep 13, 2017 | Issued |
Array
(
[id] => 12118752
[patent_doc_number] => 20180002338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS'
[patent_app_type] => utility
[patent_app_number] => 15/703945
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 20092
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15703945
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/703945 | Short-acting benzodiazepine salts and their polymorphic forms | Sep 12, 2017 | Issued |
Array
(
[id] => 16028071
[patent_doc_number] => 10676442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/329685
[patent_app_country] => US
[patent_app_date] => 2017-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 37
[patent_no_of_words] => 5996
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329685 | Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof | Aug 29, 2017 | Issued |
Array
(
[id] => 12239921
[patent_doc_number] => 20180072784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'TFPI INHIBITORS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/681074
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 179
[patent_figures_cnt] => 179
[patent_no_of_words] => 27771
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15681074
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/681074 | TFPI inhibitors and methods of use | Aug 17, 2017 | Issued |
Array
(
[id] => 14746695
[patent_doc_number] => 20190256521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => NORTHERN-SOUTHERN ROUTE TO SYNTHESIS OF BACTERIOCHLORINS
[patent_app_type] => utility
[patent_app_number] => 16/323607
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16323607
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/323607 | Northern-southern route to synthesis of bacteriochlorins | Aug 16, 2017 | Issued |
Array
(
[id] => 16590509
[patent_doc_number] => 10899759
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Positive allosteric modulators of the muscarinic acetylcholine receptor M1
[patent_app_type] => utility
[patent_app_number] => 16/337977
[patent_app_country] => US
[patent_app_date] => 2017-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21707
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337977 | Positive allosteric modulators of the muscarinic acetylcholine receptor M1 | Aug 15, 2017 | Issued |
Array
(
[id] => 16586435
[patent_doc_number] => 20210020837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => SPIROACRIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/320273
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320273
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320273 | Spiroacridine derivatives | Aug 10, 2017 | Issued |
Array
(
[id] => 13717017
[patent_doc_number] => 20170369463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => ESTERIFICATION OF 2,5-FURAN-DICARBOXYLIC ACID
[patent_app_type] => utility
[patent_app_number] => 15/674726
[patent_app_country] => US
[patent_app_date] => 2017-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674726
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674726 | Esterification of 2,5-furan-dicarboxylic acid | Aug 10, 2017 | Issued |
Array
(
[id] => 12979654
[patent_doc_number] => 20170342089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => NOVEL COMPOUNDS AS MODULATORS OF GPR-119
[patent_app_type] => utility
[patent_app_number] => 15/674376
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15674376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/674376 | NOVEL COMPOUNDS AS MODULATORS OF GPR-119 | Aug 9, 2017 | Abandoned |
Array
(
[id] => 14962923
[patent_doc_number] => 20190308939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => SALTS OF 2,6-DIMETHYLPYRIMIDONE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/316055
[patent_app_country] => US
[patent_app_date] => 2017-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316055
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316055 | Salts of 2,6-dimethylpyrimidone derivatives and uses thereof | Jul 18, 2017 | Issued |
Array
(
[id] => 14833227
[patent_doc_number] => 20190275014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING CELL DEATH
[patent_app_type] => utility
[patent_app_number] => 16/319159
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319159
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319159 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR PROMOTING NEUROGENESIS AND INHIBITING CELL DEATH | Jul 17, 2017 | Abandoned |
Array
(
[id] => 14896821
[patent_doc_number] => 20190292176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/317248
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 249342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 679
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317248 | BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS | Jul 12, 2017 | Abandoned |
Array
(
[id] => 14929765
[patent_doc_number] => 20190300520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/317218
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 417
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317218
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317218 | Bicyclic heteroaryl substituted compounds | Jul 12, 2017 | Issued |
Array
(
[id] => 17756241
[patent_doc_number] => 11396525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => C17, C20, and C21 substituted neuroactive steroids and their methods of use
[patent_app_type] => utility
[patent_app_number] => 16/316853
[patent_app_country] => US
[patent_app_date] => 2017-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64282
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316853
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316853 | C17, C20, and C21 substituted neuroactive steroids and their methods of use | Jul 10, 2017 | Issued |
Array
(
[id] => 17095310
[patent_doc_number] => 20210283101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHODS AND MATERIALS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/316182
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316182
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316182 | Methods and materials for treating cancer | Jul 6, 2017 | Issued |